E-LIB Suche - Ergebnisse für: von Minckwitz, G.

1

Adjuvant T-DM1 versus trastuzumab in patients with residual..:

Mamounas, E.P. ; Untch, M. ; Mano, M.S....
Annals of Oncology. 32 (2021) 8 - p. 1005-1014 , 2021

Link: https://doi.org/10.1016/..

2

Magnetic resonance imaging for prediction of pathologic res..:

Golshan, M. ; Wong, S. ; Loibl, S....
European Journal of Surgical Oncology. 45 (2019) 2 - p. e12-e13 , 2019

Link: https://doi.org/10.1016/..

3

Clinical comparison of the biosimilar ABP 980 and trastuzum..:

Kolberg, H.C. ; Tomasevic, Z. ; Demetriou, G.S....
European Journal of Cancer. 92 (2018) - p. S103-S104 , 2018

Link: https://doi.org/10.1016/..

4

BRCA1-like profile is not significantly associated with sur..:

van Rossum, A. G. J. ; Schouten, P. C. ; Weber, K. E....
Breast Cancer Research and Treatment. 166 (2017) 3 - p. 775-785 , 2017

Link: https://doi.org/10.1007/..

5

Expression of Cyclin D1 protein in residual tumor after neo..:

Villegas, S. L. ; Darb-Esfahani, S. ; von Minckwitz, G....
Breast Cancer Research and Treatment. 168 (2017) 1 - p. 179-187 , 2017

Link: https://doi.org/10.1007/..

6

Zoledronate for patients with invasive residual disease aft..:

von Minckwitz, G. ; Rezai, M. ; Tesch, H....
European Journal of Cancer. 64 (2016) - p. 12-21 , 2016

Link: https://doi.org/10.1016/..

7

Comprehensive Review on the Surrogate Endpoints of Efficacy..:

von Minckwitz, G. ; Fontanella, C.
JNCI Monographs. 2015 (2015) 51 - p. 29-31 , 2015

Link: https://doi.org/10.1093/..

8

PG 8.03 Clinical usefulness and relevance of intermediate e..:

Von Minckwitz, G.
The Breast. 24 (2015) - p. S14-S15 , 2015

Link: https://doi.org/10.1016/..

9

International Expert Consensus on Primary Systemic Therapy ..:

Amoroso, V. ; Generali, D. ; Buchholz, T....
JNCI Monographs. 2015 (2015) 51 - p. 90-96 , 2015

Link: https://doi.org/10.1093/..

10

1801 Neoadjuvant chemotherapy with trastuzumab or lapatinib..:

Untch, M. ; Von Minckwitz, G. ; Gerber, B....
European Journal of Cancer. 51 (2015) - p. S264 , 2015

Link: https://doi.org/10.1016/..

11

The AURORA initiative for metastatic breast cancer:

Zardavas, D ; Maetens, M ; Irrthum, A...
British Journal of Cancer. 111 (2014) 10 - p. 1881-1887 , 2014

Link: https://doi.org/10.1038/..

12

Neoadjuvante Therapie beim Mammakarzinom: Indikationen und ..:

von Minckwitz, G. ; Costa, S. ; Untch, M.
Der Onkologe. 19 (2013) 6 - p. 454-464 , 2013

Link: https://doi.org/10.1007/..

13

Optimizing taxane use in MBC in the emerging era of targete..:

von Minckwitz, G. ; Martin, M. ; Wilson, G....
Critical Reviews in Oncology/Hematology. 85 (2013) 3 - p. 315-331 , 2013

Link: https://doi.org/10.1016/..

14

11 Everolimus (Rad001) as Treatment in Breast Cancer Patien..:

Harbeck, N. ; Maass, N. ; Mundhenke, C....
European Journal of Cancer. 48 (2012) - p. S43 , 2012

Link: https://doi.org/10.1016/..

15

Early prediction of pathologic response to neoadjuvant ther..:

Marinovich, M.L. ; Sardanelli, F. ; Ciatto, S....
The Breast. 21 (2012) 5 - p. 669-677 , 2012

Link: https://doi.org/10.1016/..